Nonlinear Relationship Between AST-to-ALT Ratio and the Incidence of Type 2 Diabetes Mellitus: A Follow-Up Study

References

• Seid MA, Akalu Y, Gela YY, et al. Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia. Diabetol Metab Syndr. 2021;13(1):86. doi:10.1186/s13098-021-00704-w
   PubMed Web of Science ®Google Scholar
• Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2 diabetes in adults and children in the UK. Diabet Med. 2015;32(9):1119–1120. doi:10.1111/dme.12791
   PubMed Web of Science ®Google Scholar
• Mauricio D, Alonso N, Gratacòs M. Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab. 2020;31(4):287–295. doi:10.1016/j.tem.2020.01.007
   PubMed Web of Science ®Google Scholar
• Meigs JB. Multiple biomarker prediction of type 2 diabetes. Diabetes Care. 2009;32(7):1346–1348. doi:10.2337/dc09-0754
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol. 2015;21(3):711–725. doi:10.3748/wjg.v21.i3.711
   PubMed Web of Science ®Google Scholar
• De Ritis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. Clin Chim Acta. 1957;2(1):70–74. doi:10.1016/0009-8981(57)90027-x
   PubMed Web of Science ®Google Scholar
• Weng SF, Kai J, Guha IN, Qureshi N. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Heart. 2015;2(1):e000272. doi:10.1136/openhrt-2015-000272
   PubMed Web of Science ®Google Scholar
• Lee K, Yang JH. Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010. Metab Syndr Relat Disord. 2013;11(4):229–235. doi:10.1089/met.2012.0153
   PubMed Web of Science ®Google Scholar
• Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999;94(4):1018–1022. doi:10.1111/j.1572-0241.1999.01006.x
   PubMed Web of Science ®Google Scholar
• Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 1999;18(6):353–358. doi:10.1016/s0261-5614(99)80015-6
   PubMed Web of Science ®Google Scholar
• Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43(1):139–148. doi:10.1038/s41366-018-0076-3
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–2715. doi:10.1111/j.1572-0241.2007.01526.x
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268–274. doi:10.7326/m16-2607
   PubMed Web of Science ®Google Scholar
• Huang X-J, Choi Y-K, Im H-S, Yarimaga O, Yoon E, Kim H-S. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors. 2006;6(7):756–782.
   Web of Science ®Google Scholar
• Han HS, Kang G, Kim JS, Choi BH, Koo SH. Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med. 2016;48(3):e218. doi:10.1038/emm.2015.122
   PubMed Web of Science ®Google Scholar
• Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep. 2016;36(6). doi:10.1042/bsr20160385
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Gómez-Díaz R, Wacher NH, Rodríguez-Hernández H, Guerrero-Romero F. Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight. Eur J Gastroenterol Hepatol. 2017;29(4):435–440. doi:10.1097/meg.0000000000000811
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Wagenknecht LE, Festa A, D’Agostino RB, Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2007;30(7):1819–1827. doi:10.2337/dc07-0086
   PubMed Web of Science ®Google Scholar
• Visaria A, Pai S, Cheung M, Ahlawat S. Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults. Eur J Gastroenterol Hepatol. 2021;Publish Ahead of Print. doi:10.1097/meg.0000000000002215.
   Web of Science ®Google Scholar
• Homsanit M, Sanguankeo A, Upala S, Udol K. Abnormal liver enzymes in Thai patients with metabolic syndromes. J Med Assoc Thai. 2012;95(3):444–451.
   PubMedGoogle Scholar
• Lin S, Tang L, Jiang R, Chen Y. The relationship between aspartate aminotransferase to alanine aminotransferase ratio and metabolic syndrome in adolescents in Northeast China. Diabetes Metabol Syndr Obes: Targets Ther. 2019;12:2387–2394. doi:10.2147/dmso.s217127
   PubMed Web of Science ®Google Scholar
• Zhao L, Cheng J, Chen Y, et al. Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. Nutr Metab (Lond). 2017;14:64. doi:10.1186/s12986-017-0219-x
   PubMed Web of Science ®Google Scholar
• Goessling W, Massaro JM, Vasan RS, D’Agostino RB, Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135(6):1935–44, 1944.e1. doi:10.1053/j.gastro.2008.09.018
   PubMed Web of Science ®Google Scholar
• Yadav D, Choi E. Incremental predictive value of serum AST-to-ALT ratio for incident metabolic syndrome: the ARIRANG study. PLoS One. 2016;11(8):e0161304. doi:10.1371/journal.pone.0161304
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438. doi:10.1161/01.cir.0000111245.75752.c6
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844–1850. doi:10.2337/diabetes.50.8.1844
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689. doi:10.2337/diacare.24.4.683
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26(11):3153–3159. doi:10.2337/diacare.26.11.3153
   PubMed Web of Science ®Google Scholar
• Perera S, Lohsoonthorn V, Jiamjarasrangsi W, Lertmaharit S, Williams MA. Association between elevated liver enzymes and metabolic syndrome among Thai adults. Diabetes Metab Syndr. 2008;2(3):171–178. doi:10.1016/j.dsx.2008.04.012
   PubMedGoogle Scholar
• Zhao L, Cang Z, Sun H, Nie X, Wang N, Lu Y. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocr Disord. 2017;17(1):13. doi:10.1186/s12902-017-0165-7
   PubMed Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–1395. doi:10.1002/hep.20466
   PubMed Web of Science ®Google Scholar
• Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003;92(4):10j–17j. doi:10.1016/s0002-9149(03)00611-8
   PubMed Web of Science ®Google Scholar
• Mahran HN, Saber LM, Alghaithy AA, Elareefy AA. The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus. J Taibah Univ Med Sci. 2017;12(1):8–13. doi:10.1016/j.jtumed.2016.10.002
   PubMed Web of Science ®Google Scholar
• Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus–mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. doi:10.1038/s41575-021-00448-y
   PubMed Web of Science ®Google Scholar
• Feng X, Wen Y, Peng FF, Wang N, Zhan X, Wu: X. Association between aminotransferase/alanine aminotransferase ratio and cardiovascular disease mortality in patients on peritoneal dialysis: a multi-center retrospective study. BMC Nephrol. 2020;21(1):209. doi:10.1186/s12882-020-01840-7
   PubMed Web of Science ®Google Scholar
• Zoppini G, Cacciatori V, Negri C, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore). 2016;95(43):e4821. doi:10.1097/md.0000000000004821
   PubMed Web of Science ®Google Scholar
• McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265–1269. doi:10.1136/gut.2010.216077
   PubMed Web of Science ®Google Scholar
• Abel ED, O’Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler Thromb Vasc Biol. 2012;32(9):2068–2076. doi:10.1161/atvbaha.111.241984
   PubMed Web of Science ®Google Scholar
• Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–481. doi:10.1172/jci10842
   PubMed Web of Science ®Google Scholar
• Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24. doi:10.1007/s11684-013-0262-6
   PubMed Web of Science ®Google Scholar
• Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1(5):212–228. doi:10.1111/j.2040-1124.2010.00074.x
   PubMed Web of Science ®Google Scholar